Applying AlphaGenome Variant Impact for SNV Prioritization

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

AlphaGenome Atlas, released in September 2026, provides functional predictions for nearly all possible human single-nucleotide variants using the AlphaGenome Variant Impact (AVI) score. However, empirical thresholds relating AVI quantile rank (AVI_QUANTILE) to clinical variant classifications have not been established. We derived AVI_QUANTILE thresholds distinguishing ClinVar pathogenic (P), likely pathogenic (LP), uncertain, conflicting, likely benign, and benign SNVs using receiver operating characteristic analyses. P/LP variants were strongly enriched at the upper end of the AVI_QUANTILE distribution, yielding a Youden-optimal ClinVar-derived cutoff of 0.9938. Optimal cutoffs were generally consistent across several major molecular consequence classes, although lower thresholds were observed for selected noncoding categories. Similarly, most well-powered gene-disease groups showed cutoffs close to the global threshold, with modest gene-specific variation. Among 24,989 variants of uncertain significance, 11,357 (45.45%) exceeded the global cutoff and had AVI_QUANTILE values within the range of P/LP variants. In a steroid-dependent asthma fine-mapping analysis, AVI_QUANTILE showed little correspondence with SuSiE posterior inclusion probabilities, indicating that AlphaGenome functional predictions capture information distinct from statistical fine-mapping.

Article activity feed